January 3, 2013

An inhaler for patients with bronchospasm that includes a dose counter has become available from Teva Respiratory, the company said Thursday.

December 10, 2012

Several stores in the Giant Food Stores chain will collect used respiratory inhalers under a program sponsored by drug maker GlaxoSmithKline, the supermarket chain said.

November 19, 2012

A new University of Cincinnati study released last week examined how anxiety sensitivity can thwart the efforts of smokers with asthma to quit smoking.

October 24, 2012

Several cities across the country will play host to a new program from one drug maker to recycle respiratory inhalers.

October 10, 2012

Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.

September 27, 2012

Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies, and preventing bronchospasm during exercise, the company said.

September 20, 2012

The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said Thursday.

September 18, 2012

Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

September 18, 2012

Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow.

September 12, 2012

GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

September 10, 2012

A line of kid-friendly health and allergy alert accessories has expanded to include a new product.

August 20, 2012

Prasco Labs is distributing an authorized generic version of a respiratory drug under an agreement with the branded drug's manufacturer.

August 17, 2012

While SoloHealth is placing advanced healthcare technology in stores, Ford Motor Co. recently announced that it is introducing healthcare technology into cars with IMS Health’s Allergy Alert app, now compatible with Ford SYNC AppLink.

August 16, 2012

According to the American College of Allergy, Asthma and Immunology, 25 million adults and children across the country were diagnosed with rhinitis, or hay fever, within the last 12 months, which may lead many to believe they’ve caught an early-season cold.

August 6, 2012

The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday.

August 1, 2012

The Food and Drug Administration has approved a generic drug designed to treat asthma in children.

July 30, 2012

While most people treat nasal allergy symptoms, they often ignore their itchy, red, watery eyes. According to the Asthma and Allergy Foundation of America, approximately 40 million Americans have indoor/outdoor allergies as their primary allergy, and approximately 4% of allergy sufferers have eye allergies as their primary allergy. 


Already with a strong pedigree across eye care and ear care, Similasan recently launched its Kids Irritated Eye Relief for multisymptom relief from redness, burning, stinging and grittiness.

July 27, 2012

Horizon Pharma announced it has received regulatory approval from the Food and Drug Administration for one of its drugs.

July 16, 2012

Employees with such chronic diseases as asthma, diabetes and high blood pressure spend fewer days out of the office when they are adherent to their medications, according to new research conducted by CVS Caremark and Truven Health Analytics (previously the healthcare business of Thomson Reuters).

July 13, 2012

Vitamin D deficiency is associated with poor lung function in asthmatic children treated with inhaled corticosteroids, according to a new study from researchers in Boston released Friday.

June 21, 2012

Homeopathic supplier King Bio currently is presenting a replacement alternative for patients still seeking relief for their minor asthma symptoms in its 
AsthmaCare product.


June 21, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.

June 19, 2012

AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.

May 29, 2012

A unit of generic drug maker Mylan has settled with Sunovion Pharmaceuticals over a drug used to treat chronic obstructive pulmonary disease and asthma.